ReviewCurrent osteoporosis reports2025
A Fragile Phosphate/Pyrophosphate Balance: From Essential Mineralization to Rare Calcifying Diseases.
Review in Current osteoporosis reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purpose of reviewCalcification, the deposition of phosphate-calcium crystals, is essential for the development and function of mineralized tissues. When dysregulated, it can cause harmful effects. This review focuses on the critical role of the balance between phosphate (Pi) and pyrophosphate (PPi) in maintaining healthy mineralization and explains how disruptions in this balance contribute to rare calcifying disorders. RECENT
findingsStudies have identified key regulators of PPi production and Pi generation. Recent research on rare calcifying diseases and animal models has revealed how Pi/PPi imbalances lead to ectopic calcification in soft tissues, driving disease progression. The balance of Pi/PPi is vital for bone health and preventing pathological calcification. Disruptions in this equilibrium contribute to rare diseases. Understanding these mechanisms, supported by preclinical models, opens potential therapeutic avenues to restore balance and mitigate the impact of these diseases.
Indexed as
Identifiers
40768170What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.